|
|
|
|
| LEADER |
00000nam a22000004a 4500 |
| 001 |
6205692 |
| 003 |
ICU |
| 005 |
20071017145000.0 |
| 008 |
061115s2006 enka b 001 0 eng |
| 010 |
|
|
|a 2006285664
|
| 020 |
|
|
|a 9780198566304
|
| 020 |
|
|
|a 0198566301
|
| 040 |
|
|
|a DLC
|c DLC
|d UtOrBLW
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC933
|b .R4286 2006
|
| 245 |
0 |
0 |
|a Rheumatoid arthritis /
|c edited by Gary S. Firestein, Gabriel S. Panayi, and Frank A. Wollheim.
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Oxford ;
|a New York :
|b Oxford University Press,
|c 2006.
|
| 300 |
|
|
|a xvii, 575 p. :
|b ill. (some col.) ;
|c 29 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t Genetics of rheumatoid arthritis /
|r Peter K. Gregersen, Robert M. Plenge and Percio S. Gulko --
|g 2.
|t Epidemiology and determinants of susceptibility /
|r Jaime Calvo-Alen and Graciela S. Alarcon --
|g 3.
|t Microbes in the pathogenesis of rheumatoid arthritis /
|r Paavo Toivanen --
|g 4.
|t Experimental models for RA /
|r Rikard Holmdahl --
|g 5.
|t The role of macrophages in rheumatoid arthritis /
|r Raimund W. Kinne, Bruno Stuhlmuller, Ernesta Palombo-Kinne and Gerd-R. Burmester --
|g 6.
|t The role of T lymphocytes in rheumatoid arthritis /
|r David A. Fox --
|g 7.
|t The role of neutrophils in the pathogenesis of rheumatoid arthritis /
|r W. Winn Chatham, Jeffrey C. Edberg and Robert P. Kimberly --
|g 8.
|t The role of fibroblast-like synoviocytes in rheumatoid arthritis /
|r Ulf Muller-Ladner and Steffen Gay --
|g 9.
|t The roles of B cells in rheumatoid arthritis /
|r Gregg J. Silverman --
|g 10.
|t Innate immunity and immune complexes in rheumatoid arthritis /
|r Peter A. Nigrovic and David M. Lee --
|g 11.
|t Angiogenesis and cell trafficking /
|r Christopher D. Buckley, Andrew Filer and Costantino Pitzalis --
|g 12.
|t Cytokine networks /
|r William P. Arend and Cem Gabay --
|g 13.
|t Autoantibodies in rheumatoid arthritis : prevalence and clinical significance /
|r Gunter Steiner and Josef S. Smolen --
|g 14.
|t Mechanisms of fibroblast-mediated joint destruction /
|r Thomas Pap, Renate Gay and Steffen Gay --
|g 15.
|t Pain mechanisms in rheumatoid arthritis /
|r Bruce L. Kidd --
|g 16.
|t The stress system and the hypothalamic-pituitary-adrenal axis in rheumatoid arthritis /
|r George P. Chrousos and Gregory A. Kaltsas --
|g 17.
|t Examination of the synovium and synovial fluid /
|r Paul-Peter Tak --
|g 18.
|t Clinical aspects of rheumatoid arthritis /
|r Nathan J. Zvaifler --
|g 19.
|t Imaging in rheumatoid arthritis /
|r Mikkel Ostergaard, Marcin Szkudlarek and Bo Jannik Ejbjerg --
|g 20.
|t Susceptibility, prognosis, and mortality /
|r Marjatta Leirisalo-Repo --
|g 21.
|t Biomarkers for cartilage and bone in rheumatoid arthritis /
|r Tore Saxne, Bengt Mansson and Dick Heinegard --
|g 22.
|t NSAIDs and analgesics /
|r Richard O. Day, Lynette M. March, Garry G. Graham, Kieran F. Scott and Kenneth M. Williams --
|g 23.
|t Systemic and intra-articular glucocorticoids in rheumatoid arthritis /
|r Johannes W. J. Bijlsma, Frank Buttgereit and Johannes W. G. Jacobs --
|g 24.
|t The new frontiers in pathogenesis and treatment : methotrexate and leflunomide /
|r Rolf Rau --
|g 25.
|t Gold, antimalarials, sulfasalazine, and other DMARDs /
|r Piet L. C. M. van Riel and Eric-Jan J. A. Kroot --
|g 26.
|t Combination therapy with synthetic DMARDs in the treatment of rheumatoid arthritis /
|r Antonios O. Aliprantis and Michael Weinblatt --
|g 27.
|t Biologics in the treatment of rheumatoid arthritis /
|r Zuhre Tutuncu and Arthur Kavanaugh --
|g 28.
|t The impact of physiotherapy /
|r Ulrich Moritz --
|g 29.
|t Patient education /
|r Ylva Lindroth --
|g 30.
|t Occupational therapy and assistive products and technology /
|r Ulla Nordenskiold --
|g 31.
|t Psychological and social aspects /
|r Tore Kristian Kvien and Liv Marit Smedstad --
|g 32.
|t Non-drug management of chronic pain /
|r Wolfgang Hamann --
|g 33.
|t Health economics /
|r Leigh F. Callahan --
|g 34.
|t Large joints and feet /
|r Urban Rydholm --
|g 35.
|t The hand /
|r Christer Sollerman --
|g 36.
|t The cervical spine /
|r A. T. H. Casey and H. A. Crockard --
|g 37.
|t Design of trials involving clinical end-points /
|r Louise Pollard, Gabrielle Kingsley and David L. Scott --
|g 38.
|t Clinical trials with imaging and biomarker end-points /
|r Jane Freeston and Paul Emery --
|g 39.
|t New biologics : cytokines /
|r Jeffrey R. Curtis and Larry W. Moreland --
|g 40.
|t New biologics : T and B modulators /
|r Ernest Choy --
|g 41.
|t Inhibition of proteolytic activity involved in cartilage breakdown /
|r Tim E. Cawston and David A. Young --
|g 42.
|t Signal transduction in rheumatoid arthritis /
|r Di Chen and Edward M. Schwarz --
|g 43.
|t Mesenchymal stem cells in arthritis /
|r Frank P. Luyten.
|
| 650 |
|
0 |
|a Rheumatoid arthritis.
|0 http://id.loc.gov/authorities/subjects/sh85113649
|
| 650 |
|
7 |
|a Rheumatoid arthritis.
|2 fast
|0 http://id.worldcat.org/fast/fst01097027
|
| 700 |
1 |
|
|a Firestein, Gary S.
|0 http://id.loc.gov/authorities/names/n80133571
|1 http://viaf.org/viaf/71563176
|
| 700 |
1 |
|
|a Panayi, Gabriel S.
|q (Gabriel Stavros)
|0 http://id.loc.gov/authorities/names/n78054141
|1 http://viaf.org/viaf/93651031
|
| 700 |
1 |
|
|a Wollheim, Frank A.
|0 http://id.loc.gov/authorities/names/n99804005
|1 http://viaf.org/viaf/2764173
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)65202986
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 6fe7496b-f491-5b90-839e-67df5cbe638d
|s c05c9dba-8d9c-5908-b090-0a9ac4cfda5b
|
| 928 |
|
|
|t Library of Congress classification
|a RC933 .R4286 2006
|l ASR
|c ASR-SciASR
|i 5217662
|
| 927 |
|
|
|t Library of Congress classification
|a RC933 .R4286 2006
|l ASR
|c ASR-SciASR
|e CRERAR
|b 75673180
|i 8103573
|
